Your browser doesn't support javascript.
loading
Genome-wide association study in Turkish and Iranian populations identify rare familial Mediterranean fever gene (MEFV) polymorphisms associated with ankylosing spondylitis.
Li, Zhixiu; Akar, Servet; Yarkan, Handan; Lee, Sau Kuen; Çetin, Pinar; Can, Gerçek; Kenar, Gökce; Çapa, Fernur; Pamuk, Omer Nuri; Pehlivan, Yavuz; Cremin, Katie; De Guzman, Erika; Harris, Jessica; Wheeler, Lawrie; Jamshidi, Ahmadreza; Vojdanian, Mahdi; Farhadi, Elham; Ahmadzadeh, Nooshin; Yüce, Zeynep; Dalkiliç, Ediz; Solmaz, Dilek; Akin, Berrin; Dönmez, Salim; Sari, Ismail; Leo, Paul J; Kenna, Tony J; Önen, Fatos; Mahmoudi, Mahdi; Brown, Matthew A; Akkoc, Nurullah.
Afiliação
  • Li Z; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Akar S; Department of Internal Medicine, Division of Rheumatology, Izmir Katip Çelebi University School of Medicine, Izmir, Turkey.
  • Yarkan H; Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
  • Lee SK; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Çetin P; Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
  • Can G; Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
  • Kenar G; Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
  • Çapa F; Department of Molecular Medicine, Dokuz Eylul University Health Sciences Institute, Izmir, Turkey.
  • Pamuk ON; Department of Internal Medicine, Division of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey.
  • Pehlivan Y; Department of Rheumatology, School of Medicine, Uludag University, Bursa, Turkey.
  • Cremin K; The University of Queensland Diamantina Institute, Translational Research Institute, Brisbane, Australia.
  • De Guzman E; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Harris J; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Wheeler L; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Jamshidi A; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Vojdanian M; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Farhadi E; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Ahmadzadeh N; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Yüce Z; Department of Molecular Medicine, Dokuz Eylul University Health Sciences Institute, Izmir, Turkey.
  • Dalkiliç E; Department of Rheumatology, School of Medicine, Uludag University, Bursa, Turkey.
  • Solmaz D; Department of Internal Medicine, Division of Rheumatology, Izmir Katip Çelebi University School of Medicine, Izmir, Turkey.
  • Akin B; Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
  • Dönmez S; Department of Internal Medicine, Division of Rheumatology, Trakya University Medical Faculty, Edirne, Turkey.
  • Sari I; Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
  • Leo PJ; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Kenna TJ; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Önen F; Department of Internal Medicine, Division of Rheumatology, Dokuz Eylul University, Faculty of Medicine, Izmir, Turkey.
  • Mahmoudi M; Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Brown MA; Translational Genomics Group, Institute of Health and Biomedical Innovation, Queensland University of Technology at Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.
  • Akkoc N; Department of Internal Medicine, Division of Rheumatology, Celal Bayar University, Manisa, Turkey.
PLoS Genet ; 15(4): e1008038, 2019 04.
Article em En | MEDLINE | ID: mdl-30946743
ABSTRACT
Ankylosing spondylitis (AS) is a highly heritable immune-mediated arthritis common in Turkish and Iranian populations. Familial Mediterranean Fever (FMF) is an autosomal recessive autoinflammatory disease most common in people of Mediterranean origin. MEFV, an FMF-associated gene, is also a candidate gene for AS. We aimed to identify AS susceptibility loci and also examine the association between MEFV and AS in Turkish and Iranian cohorts. We performed genome-wide association studies in 1001 Turkish AS patients and 1011 Turkish controls, and 479 Iranian AS patients and 830 Iranian controls. Serum IL-1ß, IL-17 and IL-23 cytokine levels were quantified in Turkish samples. An association of major effect was observed with a novel rare coding variant in MEFV in the Turkish cohort (rs61752717, M694V, OR = 5.3, P = 7.63×10(-12)), Iranian cohort (OR = 2.9, P = 0.042), and combined dataset (OR = 5.1, P = 1.65×10(-13)). 99.6% of Turkish AS cases, and 96% of those carrying MEFV rs61752717 variants, did not have FMF. In Turkish subjects, the association of rs61752717 was particularly strong in HLA-B27-negative cases (OR = 7.8, P = 8.93×10(-15)), but also positive in HLA-B27-positive cases (OR = 4.3, P = 7.69×10(-8)). Serum IL-1ß, IL-17 and IL-23 levels were higher in AS cases than controls. Among AS cases, serum IL-1ß and IL-23 levels were increased in MEFV 694V carriers compared with non-carriers. Our data suggest that FMF and AS have overlapping aetiopathogenic mechanisms. Functionally important MEFV mutations, such as M694V, lead to dysregulated inflammasome function and excessive IL-1ß function. As IL-1 inhibition is effective in FMF, AS cases carrying FMF-associated MEFV variants may benefit from such therapy.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Febre Familiar do Mediterrâneo / Espondilite Anquilosante / Pirina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Aged / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Febre Familiar do Mediterrâneo / Espondilite Anquilosante / Pirina Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies Limite: Aged / Humans / Male País/Região como assunto: Asia Idioma: En Ano de publicação: 2019 Tipo de documento: Article